Scarica l'app Stockscreener
24.54
1.01%
-0.25
Dopo l'orario di chiusura:
24.54
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché PFE Giù?
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Pfizer Inc Borsa (PFE) Ultime notizie
Is Pfizer Inc. reversing from oversold territoryWeekly Profit Recap & Verified Technical Trade Signals - Newser
Pfizer's Diverse Portfolio Supports a Narrow Moat, Despite Patent Loss Headwinds - Morningstar
Pfizer's 6.9% Yield & Bullish Signal: A Prime Buying Opportunity? - sharewise.com
Monoclonal Antibodies Therapeutics Market Size Projected to Reach USD 1,057.91 Billion by 2034 - GlobeNewswire Inc.
How Pfizer Inc. (PFE) Affects Rotational Strategy Timing - news.stocktradersdaily.com
Pfizer Inc. (NYSE: PFE) Price Prediction and Forecast 2025-2030 (September 2025) - 24/7 Wall St.
Type 1 Diabetes Pipeline 2025: Comprehensive Clinical Trials and Therapies Analysis with Key MOA and ROA Insights by DelveInsight | Eli Lilly and Company, Regor Pharma, AstraZeneca, Eccogene, Pfizer - Barchart.com
Antimicrobial Therapeutics Market to Witness Massive Growth - openPR.com
3 Things You Need to Know if You Buy Pfizer Today - The Globe and Mail
Stock Analysis | Pfizer OutlookNavigating Volatility Amid Mixed Signals - AInvest
Global Vaccines Market is expected to reach US$ 108.82 billion - openPR.com
Eye Health Supplements Market Rocketing by 2032 with Industry - openPR.com
Pfizer CEO is latest to say Trump should get Nobel Peace Prize – for something much of MAGA hates - AOL.com
Cassidy, Pfizer CEO: Trump worthy of Nobel prize for COVID vaccine - AOL.com
Pfizer collaboration with Olema may spark future bidding waranalyst - MSN
Trump "worthy of the Nobel Peace Prize" for COVID vaccines, Pfizer CEO says - Axios
Pfizer, Moderna, Novavax respond to Trump’s criticism of COVID shot success - Seeking Alpha
Pfizer, Moderna defend COVID vaccine effectiveness after Trump remarks - Reuters
Prostate Cancer Pipeline Analysi, 2025 by DelveInsight | Pfizer, Janssen Pharmaceutical, POINT Biopharma, Tavanta Therapeutics, Exelixis, Astellas Pharma Inc., Antev, ORCA Therapeutics, Regeneron Phar - Barchart.com
Pfizer responds to Trump’s call for Covid-19 vaccine data, says Operation Warp Speed deserves Nobel Peace Prize - News Channel 3-12
Pfizer defends COVID-19 vaccine effectiveness after Trump remarks - Reuters
Responding to Trump, Pfizer CEO Bourla stands by Covid-19 vaccine data - Endpoints News
Pfizer (PFE) Partners With Olema For New Metastatic Breast Cancer Study - simplywall.st
Pfizer Reaffirms Transparency Commitment On COVID-19 Vaccine Data - Nasdaq
Pfizer Defends Covid Shot, Says Trump Deserves Nobel Prize - Yahoo Finance
Pfizer to Continue Disclosing Research Analysis of COVID-19 Vaccine; Calls Operation Warp Speed 'Success' - MarketScreener
Pfizer defends Covid-19 vaccine transparency in response to Trump - The Edge Malaysia
Pfizer reaffirms commitment to COVID-19 vaccine transparency - Investing.com
Pfizer Defends Covid Vaccine Transparency in Response to Trump - Bloomberg.com
Pfizer : Responds to Success of Operation Warp Speed and Reaffirms Transparency of COVID Vaccine Data - MarketScreener
Pfizer says it will soon share new data on latest vaccine strain which FDA approved - MarketScreener
Stomach Cancer Treatment Market Review 2020-2024 and Forecast 2025-2030 - GlobeNewswire Inc.
Pfizer (PFE) Volatility and Risk Allocation: Navigating a Shifting Pharmaceutical Landscape - AInvest
Pfizer's Strategic Reinvention: Execution Discipline and Risk Allocation Reshape Valuation Narrative - AInvest
Pfizer's Strategic Volatility: Tactical Entry Points and Rule-Based Trading in a Biotech Recovery - AInvest
Pfizer's Strategic Volatility: Decoding Recent Share Price Swings and Tactical Entry Points - AInvest
Pfizer's Surging Momentum: A Catalyst for Large-Cap Biotech Growth - AInvest
$33M Pfizer Antitrust Deal OK'd, First MDL Trial Date Set - Law360
Pfizer's Golden Cross and Pipeline Progress: A Dividend-Driven Turnaround or a Value-Trap Mirage? - AInvest
Pfizer's Pipeline Monetization and 7% Yield: A Dual-Engine Opportunity in a Re-Rating Pharma Landscape - AInvest
Pfizer Inc. (PFE) Is a Trending Stock: Facts to Know Before Betting on It - Yahoo Finance
Pfizer Defends Transparency On COVID-19 Vaccine Data, Says Trump’s ‘Operation Warp Speed’ Effort Deserves Nobel Peace Prize - Stocktwits
Backtesting results for Pfizer Inc. trading strategiesTrade Risk Report & Safe Entry Trade Signal Reports - Newser
Can Pfizer Inc. recover in the next quarterTrade Signal Summary & Daily Chart Pattern Signal Reports - Newser
Olema stock jumps after new clinical trial collaboration with Pfizer - Investing.com
B-cell Lymphoma Pipeline 2025: Key Companies, MOA, ROA, and Clinical Trials Evaluation by DelveInsight | Biegene, Oncternal Therapeutics, Inc, ZAI Lab, Pfizer, Xynomic Pharma, SystImmune Inc - Barchart.com
Precision Trading with Pfizer Inc. (PFE) Risk Zones - news.stocktradersdaily.com
Pfizer: Pipeline Monetization Shows Great PromiseRich Yields Pending Re-Rating (NYSE:PFE) - Seeking Alpha
Is Pfizer Stock Underperforming The Nasdaq? - Barchart.com
Olema Pharmaceuticals, Pfizer Collaborate for Clinical Trial of Breast Cancer Treatment - MarketScreener
Olema Pharmaceuticals Partners with Pfizer for New Trial - TipRanks
Olema Oncology Announces New Clinical Trial Agreement with Pfizer to Combine Palazestrant with Atirmociclib in ER+/HER2- Metastatic Breast Cancer - The Manila Times
Pfizer, Moderna in focus as Trump demands answers on COVID success - Seeking Alpha
Olema Oncology Announces New Clinical Trial Agreement with - GlobeNewswire
Novel Breast Cancer Treatment: Olema and Pfizer Join Forces on Promising Drug Combination Study - Stock Titan
Pfizer (PFE) Valuation in Focus Following FDA Approval of Updated COVID-19 Vaccine - simplywall.st
Contract Pharma Talks with Bruno Sciamanna and Lillian Glennon of Pfizer CentreOne - Contract Pharma
Pfizer Inc. (PFE)’s Updated COVID-19 Vaccine COMIRNATY LP.8.1 Gets FDA Approval, Ships Nationwide - Yahoo Finance
Trump Demands Pfizer, Other Covid Drug Makers To… - inkl
Unit Dose Packaging Market Top Companies StudyPfizer Inc., - openPR.com
Is Pfizer Inc. trending in predictive chart modelsWeekly Profit Summary & Real-Time Buy Signal Notifications - Newser
0.19%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):